AlphaYouEC
Insider selling
Edward Carr sold $2M of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock
Edward Carr, Chief Accounting Officer of Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 20,000 shares of DNTH stock worth $2M, per an SEC Form 4 filed Sep 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 17, 2026, 1 day before it was made public.
DNTH has moved -2.7% since the trade date, from $101.12 to $98.35 (Sep 22, 2026 close).
- Traded
- Sep 17, 2026
- Disclosed
- Sep 18, 2026
- Filing delay
- 1 day
- Price since
- -2.7%
- Role
- Chief Accounting Officer
- Source
- SEC Form 4
More DNTH insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.